We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLS:ASXPLS Group Limited Analysis

Data as of 2026-03-14 - not real-time

A$4.89

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The 20‑day SMA sits above the 50‑day SMA, confirming a bullish price trend. The 200‑day SMA remains well below the current price, reinforcing long‑term upside. RSI is around the mid‑50s, indicating the stock is not overbought. MACD histogram has turned slightly negative, and the signal line is flagged bearish, suggesting short‑term pressure. Volume has been trending down, while 30‑day volatility is high at roughly 60 %. Current price trades above the identified support but below the 52‑week high, leaving limited upside to the resistance level.
Revenue has surged nearly 47 % YoY, and forward EPS is projected to turn positive. EBITDA remains healthy, yet the company reports a negative profit margin and a high debt‑to‑equity ratio above 20 ×. DCF analysis values the shares near $2.4, well below the market price, implying the stock is currently overvalued. Analyst sentiment has been upgraded recently, with several forecasts calling for a strong rebound. The company’s strong cash balance cushions its leverage, but the lack of dividend and high valuation temper enthusiasm. Overall, the blend of bullish technical trend, solid top‑line growth, and valuation concerns suggests a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD signal and decreasing volume
  • Current price near resistance with limited upside
  • DCF valuation far below market price indicating overvaluation

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and positive forward EPS
  • Analyst upgrades and bullish technical trend
  • Robust cash position offsetting high debt

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Lithium demand tailwinds and flagship Pilgangoora project
  • Sustained top‑line expansion potential
  • Improving profitability outlook as margins stabilize

Key Metrics & Analysis

Financial Health

Revenue Growth46.60%
Profit Margin-9.67%
P/E Ratio25.3
ROE-2.77%
ROA0.09%
Debt/Equity20.17
P/B Ratio4.4
Op. Cash FlowA$285.5M
Free Cash FlowA$-93887376

Technical Analysis

TrendBullish
RSI55.5
SupportA$4.11
ResistanceA$5.32
MA 20A$4.70
MA 50A$4.63
MA 200A$3.05
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$2.39
Target PriceA$4.54
Upside/Downside-7.13%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.96
Volatility59.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.